CARISMA THERAPEUTICS
Live / Registered — Registered (as of 20 Aug 2024)
What this means for you
Registered since 20 Aug 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Aug 2030: the §8 declaration of use).
Record
- Serial number
- 90179264
- Registration number
- 7482488
- Mark type
- Word mark
- Filed
- 14 Sept 2020
- Published for opposition
- 02 Mar 2021
- Registered
- 20 Aug 2024
- Next maintenance filing
- §8 declaration of use, due by 20 Aug 2030 (grace period to 20 Feb 2031)
- Attorney of record
- Sara M. Bauer
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations, namely, preparations for use in the treatment of cancer and tumors; biologic preparations for medical and therapeutic purposes for immunotherapy; biological preparations for immunotherapy, including, macrophage platforms and T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
Owner
- Carisma Therapeutics Inc., Philadelphia, PA, US
- Carisma Therapeutics Inc., Philadelphia, PA, US
- Carisma Therapeutics Inc., Philadelphia, PA, US
Prosecution history
- 20 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Jul 2024 — NON-FINAL ACTION E-MAILED
- 14 Jul 2024 — SU - NON-FINAL ACTION - WRITTEN
- 21 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Jun 2024 — ASSIGNED TO LIE
- 26 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Feb 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Feb 2024 — NON-FINAL ACTION E-MAILED
- 02 Feb 2024 — SU - NON-FINAL ACTION - WRITTEN
- 23 Jan 2024 — STATEMENT OF USE PROCESSING COMPLETE